Figure 2
(A) Quantification of mRFPovTSP1C expressing cells after treatment with various inhibitors for 18 h. (B) Quantification of ECM deposition patterns after treatment with the various inhibitors for 18 h. (C and D) Levels of mRFPovTSP1C present in conditioned media (CM): (C) or total cell lysate (TCL) (D) after treatment of transfected cells with the various inhibitors for 18 h. Proteins were resolved on 10% SDS/PAGE gels under reducing conditions. Molecular mass markers are in kDa. In (A and B), columns represent the mean and bars indicate S.E.M. from three independent experiments. ***P<0.001.
Effects of inhibitors of actin or actin-related pathways on ECM patterning of mRFPovTSP1C

(A) Quantification of mRFPovTSP1C expressing cells after treatment with various inhibitors for 18 h. (B) Quantification of ECM deposition patterns after treatment with the various inhibitors for 18 h. (C and D) Levels of mRFPovTSP1C present in conditioned media (CM): (C) or total cell lysate (TCL) (D) after treatment of transfected cells with the various inhibitors for 18 h. Proteins were resolved on 10% SDS/PAGE gels under reducing conditions. Molecular mass markers are in kDa. In (A and B), columns represent the mean and bars indicate S.E.M. from three independent experiments. ***P<0.001.

Close Modal

or Create an Account

Close Modal
Close Modal